combretastatin b-1 has been researched along with cytarabine in 1 studies
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
| Studies (combretastatin b-1) | Trials (combretastatin b-1) | Recent Studies (post-2010) (combretastatin b-1) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 8 | 0 | 3 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | combretastatin b-1 (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosse, RC; Chaplin, DJ; Cogle, CR; Drusbosky, L; Meacham, A; Purich, DL; Siemann, DW; Walter, GA; Wasserstrom, B; Wise, E | 1 |
1 other study(ies) available for combretastatin b-1 and cytarabine
| Article | Year |
|---|---|
Chemosensitizing AML cells by targeting bone marrow endothelial cells.
Topics: Acute Disease; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Adhesion; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coculture Techniques; Cytarabine; Endothelial Cells; Flow Cytometry; Humans; Leukemia, Myeloid; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Microscopy, Confocal; Reactive Oxygen Species; Stilbenes; Time Factors; Xenograft Model Antitumor Assays | 2016 |